Successful Application of a Virus-Modified Tumor Vaccine for Anti-Metastatic Cancer Immunotherapy
Metastasis is a complex multistep process influenced by tumor cell properties as well as by properties of the host. This is best exemplified with immunological tumor-host interactions. The aim of this presentation is to explore the possibilities of immunological interventions in metastasis. Various approaches have been tried in the past, such as the passive transfusion of monoclonal antibodies or of different types of cells of the immune system, such as NK cells, T cells, LAK cells (lymphokine activated killer cells) or TIL cells (tumor infiltrating lymphocytes). Other approaches aim at nonspecific activation of host defense mechanisms by biological response modifiers (biological or chemical reagents).
KeywordsTumor Antigen Newcastle Disease Virus Active Specific Immunotherapy Normal Spleen Cell Active Specific Immunization
Unable to display preview. Download preview PDF.
- Altevogt P, von Hoegen P, Schirrmacher V (1986a) The effects of mutagens on the immunogenicity and antigenicity of murine high and low metastatic lymphomas. Proceedings of the 14th international cancer congress, Budapest, pp 21/27Google Scholar
- Altevogt P, von Hoegen P, Schirrmacher V (1986 b) Immunoresistant metastatic tumor variants can reexpress their tumor antigen by treatment with agents that inhibit DNA-methylation. Int J CancerGoogle Scholar
- Schirrmacher V, Bosslet K, Altevogt P, Rußmann E, Beck L, Fogel M (1982a) Microenvironmental influences on tumor-host interactions studies with high and low metastatic tumor lines. Tumor progression and markers. Proceedings IV. meeting of EACR, Budapest 1981, Kugler, Amsterdam, pp 155–164Google Scholar
- Schirrmacher V, von Hoegen P, Heicappell R, Altevogt P (1986a) Modulations of tumor cell immunogenicity leading to increased T cell reactivity and decreased metastasis formation. In: Herberman RB, Wiltrout R, Gorelik E (eds) Immune responses to metastases. CRC Press, Boca RatonGoogle Scholar
- Schirrmacher V, Braun M, Waller CA, Benke R, Larizza L (1986b) Changes in adhesive, invasive and metastatic capacity of a T lymphoma after fusion with a bone marrow derived macrophage. In: Macher E, Sorg C (eds) Local immunity in cancer. Reyen and Biermann, pp 72–83Google Scholar
- Schirrmacher V, Ahlert T, Heicappell R, Appelhans B, von Hoegen P (1986c) Successful application of non-oncogenic viruses for anti-metastatic cancer immunotherapy. Cancer RevGoogle Scholar
- Storch E, Kirchner H, Schirrmacher V (1986) Prolonged survival of mice against the Eb and ESb lymphoma by treatment with interferon inducers alone or in combination with Corynebacterium parvum. Cancer Immunol ImmunotherGoogle Scholar